ARCHIVES

Stone(y) Silence Didn’t Save His Job; Niamd’s Rall Rumored as Top Choice As New NIH Director

This article is from The Cancer Letter archive.

Vol. 01 No. 46 | December 20, 1974

Download PDF Visit The Full Archive

Related Articles

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013

Program Announcement: Breast Cancer Research

May 28, 1993

Project Expands Group Studies To Community Oncologists.

March 10, 2000

Yarbro Proposal, Clinical Research Should Be “Fun”, Done Without Grants/ Contracts, To Be Heard By ACCC

September 10, 1982

Colorectal Cancer Screening Programs Could Cut Future Treatment Costs

September 25, 2009